Western Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,756
| Closed | -$201K | – | 713 |
|
|
2023
Q3 | $201K | Buy |
+2,756
| New | +$201K | 0.02% | 614 |
|
|
2022
Q4 | – | Sell |
-4,380
| Closed | -$347K | – | 805 |
|
|
2022
Q3 | $347K | Buy |
4,380
+1,360
| +45% | +$108K | 0.02% | 593 |
|
|
2022
Q2 | $221K | Sell |
3,020
-301
| -9% | -$22K | 0.01% | 708 |
|
|
2022
Q1 | $298K | Buy |
+3,321
| New | +$298K | 0.01% | 679 |
|
|
2021
Q2 | – | Sell |
-2,057
| Closed | -$279K | – | 636 |
|
|
2021
Q1 | $279K | Buy |
+2,057
| New | +$279K | 0.04% | 421 |
|
|
2020
Q1 | – | Sell |
-2,380
| Closed | -$226K | – | 428 |
|
|
2019
Q4 | $226K | Buy |
+2,380
| New | +$226K | 0.03% | 364 |
|
|
2019
Q3 | – | Sell |
-2,270
| Closed | -$200K | – | 422 |
|
|
2019
Q2 | $200K | Sell |
2,270
-105
| -4% | -$9.25K | 0.03% | 391 |
|
|
2019
Q1 | $215K | Buy |
+2,375
| New | +$215K | 0.05% | 353 |
|